daclatasvir dihydrochloride - medicine shortage information

Back to CRITICAL Shortages     Back to ALL Shortages

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist. In most cases your doctor and pharmacist will know about the possible substitute medicines to continue your care.

In some cases the Supply Detail section below will provide information about the special arrangements that are in place for your health professional to prescribe or supply a substitute medicine. These may include reference to Special Access Scheme or "Under section 19A"

Product details Supply Impact Dates Further Details
DAKLINZA daclatasvir (as dihydrochloride) 30 mg tablet blister
AUST R: 222743
Active ingredients:
daclatasvir dihydrochloride

Sponsor:
Bristol-Myers Squibb Australia Pty Ltd

Phone:
1800 629 273

Deletion from market:
01 Oct 2020

Status:
Discontinued

Patient impact:
Low

Availability:
Unavailable

Reason:
Commercial Changes

DAKLINZA daclatasvir (as dihydrochloride) 60 mg tablet blister
AUST R: 222742
Active ingredients:
daclatasvir dihydrochloride

Sponsor:
Bristol-Myers Squibb Australia Pty Ltd

Phone:
1800 629 273

Deletion from market:
01 Oct 2020

Status:
Discontinued

Patient impact:
Low

Availability:
Unavailable

Reason:
Commercial Changes